Precision Biosciences
IPO News: Filed S-1/A: Precision Biosciences Launches 7.9mm Share IPO with $15.00 - $17.00 Marketing Range
Precision Biosciences

Precision Biosciences

NASDAQ: DTIL

Initial Filing Date: 03/01/19

Launch Date: 03/18/19

Price Range: $15.00 - $17.00

Initial Shares Offered (mm): 7.9

Shares Offered (Pre-Shoe | mm): 7.9

Primary Shares (mm): 7.9

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $126.4

% Secondary: 0.0%

Shares Outstanding (mm): 49.0

Market Value at Midpoint (mm):  $784.5

Offering as % of Market Value: 16.1%

Bookrunners: JPM | GS | JEFF | BARC       

Major Holders: venBio Global Strategic Fund | F-Prime Capital Partners Healthcare Fund  | Matthew Kane (CEO) | Jeff Smith (CTO)

Industry: Healthcare

Description: Precision Biosciences is a genome editing company dedicated to improving life through their groundbreaking proprietary genome editing platform, “ARCUS."

Note: Emerging Growth Company

Launch Link: S-1/A